Plant Advanced Technologies SA (ALPAT.PA)
EUR 10.5
(0.0%)
EUR 10.5
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.07 EUR | 108.97% |
| 2022 | -0.78 EUR | 25.0% |
| 2021 | -1.04 EUR | -108.0% |
| 2020 | -0.50 EUR | 0.0% |
| 2019 | -0.50 EUR | -156.82% |
| 2018 | 0.88 EUR | 220.55% |
| 2017 | -0.73 EUR | 41.6% |
| 2016 | -1.25 EUR | -26.26% |
| 2015 | -0.99 EUR | -6.45% |
| 2014 | -0.93 EUR | -745.45% |
| 2013 | -0.11 EUR | 78.85% |
| 2012 | -0.52 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 FY | - EUR | 108.97% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q4 | 0.19 EUR | 0.0% |
| 2022 FY | - EUR | 25.0% |
| 2022 Q2 | -0.97 EUR | 0.0% |
| 2021 Q4 | -0.05 EUR | 0.0% |
| 2021 FY | - EUR | -108.0% |
| 2021 Q2 | -1.00 EUR | 0.0% |
| 2020 Q4 | 0.04 EUR | 0.0% |
| 2020 FY | - EUR | 0.0% |
| 2020 Q2 | -0.66 EUR | 0.0% |
| 2019 FY | - EUR | -156.82% |
| 2019 Q4 | -0.07 EUR | 0.0% |
| 2019 Q2 | -0.48 EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 FY | - EUR | 220.55% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 FY | - EUR | 41.6% |
| 2017 Q2 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 FY | - EUR | -26.26% |
| 2016 Q4 | - EUR | 0.0% |
| 2015 FY | - EUR | -6.45% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2014 FY | - EUR | -745.45% |
| 2014 Q2 | -0.97 EUR | 0.0% |
| 2014 Q4 | 0.03 EUR | 0.0% |
| 2013 Q1 | -0.03 EUR | 0.0% |
| 2013 Q3 | -0.03 EUR | -4366.67% |
| 2013 Q4 | 0.00 EUR | 101.87% |
| 2013 FY | - EUR | 78.85% |
| 2013 Q2 | -0.00 EUR | 97.76% |
| 2012 Q2 | 0.07 EUR | 0.0% |
| 2012 Q3 | 0.07 EUR | 0.0% |
| 2012 Q4 | -0.03 EUR | -140.61% |
| 2012 FY | - EUR | 0.0% |
| 2012 Q1 | 0.07 EUR | 0.0% |
| 2011 Q4 | 0.07 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | 158.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 102.041% |
| Adocia SA | -1.91 EUR | 103.665% |
| Aelis Farma SA | -0.39 EUR | 117.949% |
| Biophytis S.A. | -12.55 EUR | 100.558% |
| Advicenne S.A. | -0.67 EUR | 110.448% |
| genOway Société anonyme | 0.17 EUR | 58.824% |
| IntegraGen SA | -0.03 EUR | 370.27% |
| Medesis Pharma S.A. | -0.80 EUR | 108.75% |
| Neovacs S.A. | -0.00 EUR | 2900.0% |
| NFL Biosciences SA | -0.46 EUR | 115.217% |
| Quantum Genomics Société Anonyme | -0.09 EUR | 176.923% |
| Sensorion SA | -0.17 EUR | 141.176% |
| Theranexus Société Anonyme | -0.88 EUR | 107.955% |
| TME Pharma N.V. | -1.34 EUR | 105.224% |
| Valbiotis SA | -0.59 EUR | 111.864% |
| TheraVet SA | -0.49 EUR | 114.286% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | 146.667% |
| DBV Technologies S.A. | -0.71 EUR | 109.859% |
| Genfit S.A. | -0.58 EUR | 112.069% |
| GeNeuro SA | -0.59 EUR | 111.864% |
| Innate Pharma S.A. | -0.09 EUR | 174.389% |
| Inventiva S.A. | -2.43 EUR | 102.881% |
| MaaT Pharma SA | -1.73 EUR | 104.046% |
| MedinCell S.A. | -0.88 EUR | 107.955% |
| Nanobiotix S.A. | -1.08 EUR | 106.481% |
| OSE Immunotherapeutics SA | -1.18 EUR | 105.932% |
| Poxel S.A. | -0.91 EUR | 107.692% |
| GenSight Biologics S.A. | -0.54 EUR | 112.963% |
| Transgene SA | -0.22 EUR | 131.818% |
| Valneva SE | -0.73 EUR | 109.589% |